Background. Angiotensin II promotes growth of vascular smooth muscle cells in vitro via the autocrine production of growth factors such as platelet-derived growth factor, basic fibroblast growth factor, and transforming growth factor-a3. Furthermore, experimental studies have demonstrated that angiotensin infusion can enhance smooth muscle proliferation after balloon injury in vivo. Consistent with this, angiotensin converting enzyme inhibitors have been shown to prevent myointimal proliferation. The origin of vascular angiotensin that participate in this process is of interest. We have demonstrated the presence of angiotensinogen messenger RNA (mRNA) in the adventitial and medial layers of the rat aorta and have speculated that local angiotensinogen production may play an important role during myointimal proliferation. To provide further evidence toward this hypothesis, we compared the localization and expression of angiotensinogen mRNA in control and balloon injured vessels using in situ hybridization.
T he endothelium plays an important role in maintaining normal vascular homeostasis by producing vasoactive and growth regulatory substances. 1 In the presence of a normal endothelium, vascular tone and structure are maintained. Removal of the endothelium by balloon injury results in the migration of medial smooth muscle cells (SMCs), which then undergo proliferation to form a lesion known as myointimal hyperplasia.2-4 Several investigators have reported the expression of platelet-derived growth factor (PDGF) and transforming growth factor-X (TGF-P) in the SMC within this lesion.56 These endogenous growth factors presumably take part in the proliferative process. However, the exact stimulus for the migration, proliferation, and expression of growth factors by these cells is not known.
Angiotensin (Ang) II is a powerful vasoconstrictor that has been shown to promote both hypertrophic and hyperplastic growth of vascular SMCs both in culture and in vivo. Blockade of Ang II synthesis with angiotensin converting enzyme (ACE) inhibitors has been shown to block hypertension-induced hypertrophy7 and injuryinduced hyperplasia4 of the vessel wall. Moreover, the hyperplastic growth in response to injury can also be prevented with a specific Ang II receptor antagonist, DuP 753. 8 The inhibition of hyperplastic growth is not due to the decrease in blood pressure since verapamil did not affect lesion development despite an equal lowering of blood pressure.4 Consistent with these results, Daemen et a19 have shown that infusion of Ang II increases the rates of DNA synthesis in the injured and uninjured vessel wall. These data suggest that Ang II plays a role in the pathogenesis of myointimal hyperplasia. Indeed, data have demonstrated that Ang II possesses growth-promoting properties in vitro.
The origin of the vascular Ang II that participates in the proliferative response is unknown. Ang II may originate from the circulation but also may be locally synthesized by a vascular renin-angiotensin system. Experimental evidence suggests that components of this system are present in the vessel wall.'0 We and others have demonstrated the presence of renin by immuno-histochemistry10 and angiotensinogen messenger RNA (mRNA) using Northern-blot analysis and in situ hybridization techniques." Angiotensinogen mRNA is localized to the medial smooth muscle and the periadventitial fat. Interestingly, the levels of medial angiotensinogen mRNA are locally regulated by low sodium diet and sympathetic activation, whereas those in the periadventitial fat are not. In addition, in vivo as well as in vitro data have demonstrated the local production of angiotensin in the vessel wall.'2'13
The purpose of the present study was to examine the localization and expression of the mRNA encoding angiotensinogen, a key component of the system, within the vessel wall during myointimal proliferation in response to balloon injury. Methods
Animals and Tissue Processing
Male Sprague-Dawley rats (weight, 450-500 g) were anesthetized with sodium pentobarbital (20 mg/kg i.p.). A 2F embolectomy balloon catheter was passed into the aorta via the femoral artery and placed distal to the renal arteries. The balloon was inflated to a pressure of about 2 atm and withdrawn slowly to the aortic bifurcation. This procedure was repeated two more times. Using Evans blue staining, we documented that this procedure denuded effectively the endothelium.
At the time of tissue harvest, noninjured and injured rats were anesthetized with ether and perfused at a pressure of 110 mm Hg through the ascending aorta with 100 ml phosphate-buffered saline (PBS; pH 7.2), followed by 80 ml of freshly prepared PBS containing 4% paraformaldehyde.
The abdominal aorta was removed from the branch of the left renal artery to the aortic bifurcation and cut to the three portions (proximal, mid, and distal). Postfixation was performed in the same fixative as above at 40C for 4 hours, after which the tissue was embedded in paraffin. The midportion of the abdominal aorta was used for the following studies.
Morphometric Analysis
To estimate the size of the intimal lesion, multiple 6-,um cross sections of each vessel were stained with hematoxylin and eosin, photographed under low power, and projected onto a screen. The lesion and the vessel wall were traced carefully. The region of maximal thickness of the neointima was measured, and the intimal-to-medial thickness was calculated.
In Situ Hybridization
Six-micron sections were cut on a rotary microtome and placed on glass slides that had been treated for 20 seconds with acetone containing 2% 3-amino-propyltriethoxysilane (Sigma Chemical Co., St. Louis, Mo.). Injured and control tissue were placed side by side on one slide. Prehybridization and hybridization were performed with a modification of our previously described protocol."' In brief, slides were dewaxed and sequentially passed through 0.2 M HCl, 10 ,ug/ml proteinase K, 2 mg/ml glycine, 4% paraformaldehyde, and 0.5% acetic anhydride in 0.1 M triethanolamine. After rinsing in PBS, slides were successively dehydrated in graded ethanol. Sections were then hybridized with 500,000 cpm/slide of 35S-labeled RNA (see below) in 50% deionized formamide, 300 mM NaCl, 5 mM EDTA, 20 mM Tris HCl, 0.02% polyvinylpyrolidone, 0.02% Ficoll, 0.02% BSA, 10 mM dithiothreitol, 0.1 mg/ml yeast t-RNA, and 10 mM vanadyl ribonucleoside inhibitor for 15 hours at 42°C in a sealed, humidified container. Slides were then washed in 4xSSC [1xSSC=0.15 M NaCI, 0.01 M Na citrate (pH 7.0)] containing 20 mM 2-mercaptoethanol for 90 minutes at 45°C, treated with 10 ,g/ml RNAse A for 30 minutes at 37°C, and washed in 2xSSC and 10 mM dithiothreitol for 90 minutes at 50°C. Finally, slides were washed in 0.1xSSC and 10 mM dithiothreitol for 90 minutes at 50°C. Dehydrated slides were dipped in diluted photographic emulsion (NTB-2, Eastman Kodak Co.), and exposed for 4-6 weeks at 4°C. The slides were developed with D-19 
0.17±0.03
Values in the first three rows represent the specific radiolabeled grains within an area of 968 gm2. Values in the last two rows represent the ratio of grains in media or intima to the equivalent area of adventitia. All values are mean± SEM or mean. The proliferative intima appeared in only two of four animals at 1 week after injury. *p<0.05 compared with control (n=4). ... 0.03±0.01 Values in the first three rows represent grains per field divided by the number of nuclei within the same field, yielding specific grains per nuclei. Values in the last two rows represent the ratio of these data in media or intima to adventitia. All values are mean±SEM or mean. The proliferative intima appeared in only two of four animals at 1 week after injury.
*p<0.05 compared with control (n=4).
developer (Eastman Kodak Co.), counterstained with hematoxylin and eosin, examined on a Nikon microscope, and photographed. Probe Preparation A 716-(base pairs) bp BamHI fragment of pRang 1650, a rat angiotensinogen complementary DNA (cDNA),14 was subcloned into Bluescribe vector. 35S-Labeled antisense and sense complementary RNAs (cRNAs) were generated as previously described." Controls for in situ hybridization were performed with serial cross sections adjacent to the experimental cross section whenever possible; these included a cRNA sense probe for angiotensinogen and 40 ,ug/ml RNAse treatment (for 30 minutes at 37°C) before hybridization with the antisense probe.
Quantification of Hybridization In Situ
Radiolabeled grains and nuclei within an area of 25.4x38.1 ,um (968 Ium2) were counted by hand at a magnification of x 1,000. At least two areas were counted per section, each area was counted twice, and the grain counts were averaged. The number of grains over antisense hybridized tissue was counted. The nonspecific tissue count was determined from the number of grains on serial sections of tissue that had been hybridized to sense probes and tissue treated with RNAse before hybridization. The average of these background signals was then subtracted from the total tissue count of the antisense hybridized tissue to yield the specific tissue count. The average signal-to-noise ratio was 9.5±1.0. The results were then expressed as specific grains per field or specific grains per nuclei. The number of specific grains per field is dependent on numerous parameters such as emulsion age, specific activity of the probe, exposure time, developer age, and development time. Therefore, for comparison between blood vessel sections, the specific grains per field for the intima and media were normalized to the specific grains per field in the adventitia. Although this calculation will normalize signals on different sections, care must be used in the analysis of the results (see "Discussion").
The specific grains per field for the control adventitia (138±15, n =9) was not significantly different from that of the pooled injured animals (130±14, n = 12).
Results were expressed as mean±SEM. Data were analyzed by ANOVA. Multiple comparisons were then made using Duncan's multiple-range test.
Results
Light photomicrographs of control uninjured aorta indicated that the ratio of intimal to medial thickness was negligible. The thickness of the intima increased progressively after injury (1 week, 14±8 ,um; 2 weeks, 56±22 ,um; 6 weeks, 91±7 ,um; n=4 per time point).
The intimal-to-medial thickness increased from essentially zero in the uninjured to 0.17±0.09 at 1 week, 0.68±0.24 at 2 weeks, and 1.17±0.13 at 6 weeks (n=4 per time point). These increases were statistically significant (p<0.05).
Angiotensinogen mRNA was clearly detected in the adventitia and media of uninjured ( Figure 1A ) and injured aorta (Figures 2A and 2B ). The specificity of hybridization was verified by hybridization with a sense probe ( Figure 1B) or RNAse pretreatment before hybridization ( Figure 1C ), which demonstrated minimal signals. The signal observed in the intima of uninjured aorta did not show significant difference from nonspecific signals in the control slides. However, angiotensinogen mRNA was easily detected in the neointima of the injured aorta in levels that were significantly higher than background (Figures 3B, 3C, and 3D ).
We next attempted to quantitate the signals in the different vascular regions. Grain counts were performed as described in "Methods," and the counts were normalized to the signal observed in the adventitia. Although this calculation will eliminate signal variation from section to section, care must be observed in the analysis of the results (see "Discussion"). Over the course of the 6-week experiment, the ratio of grains in the media to those in the adventitia did not change significantly in the control animals (Table 1 ). On the other hand, the ratio of medial to adventitial angiotensinogen mRNA levels in the injured aorta was highest 1 week after injury-2.5 -fold greater than that seen in control aorta. That ratio decreased over time such that at 6 weeks, there no longer was a significant difference between injured and control vessel.
Similar analysis was performed with the intima ( Table  1 ). The ratio of angiotensinogen mRNA signal in the neointima to adventitia at 2 weeks after injury (0.39+±0.03) was significantly higher than at 6 weeks (0.17±0.03, p<0.01). Proliferative neointima appeared in only two of four animals at 1 week after injury; however, the mean of the ratio of angiotensinogen mRNA levels in intima to adventitia (0.40) at 1 week was similar to that at 2 weeks after injury.
The above experiment was recalculated expressing the results as the number of grains per nuclei rather than number of grains per field. The results were qualitatively similar, i.e., the levels of angiotensinogen mRNA were greatest in both the media and intima in the first few weeks after injury ( Table 2) .
Discussion The results of the present study demonstrate the induction of the expression of angiotensinogen mRNA within the injured aorta. Previously, we and others9 '5,16 have demonstrated the presence of angiotensinogen mRNA within the vessel wall by Northern-blot as well as by in situ hybridization. Those results, confirmed in the present study, indicated that angiotensinogen mRNA levels are significantly higher in the adventitia than in the medial layer.
In our previous report," with Wistar and Wistar-Kyoto rats, the ratio of medial to adventitial angiotensinogen mRNA levels was approximately 0.4 under high or normal salt diet but increased to 1.0 under sodium restriction. In the present study using Sprague-Dawley rats, the ratio under control conditions was 0.22, which increased to 0.55 1 week after injury. This increase was transient since the ratio decreased to levels indistinguishable from control by 6 weeks. The increased ratio of medial to adventitial angiotensinogen mRNA levels 1 week after injury suggests an induction of the expression of this gene in the medial layer after endothelium removal. Since the endothelium is an important physical barrier, its removal by balloon denudation may result in the direct exposure of the medial SMCs to circulating factors such as angiotensin or steroid hormones that are capable of stimulating angiotensinogen production.'7 In addition, the endothelium may produce inhibitory factors that attenuate the production of vascular angiotensinogen such that the removal of the endothelium may lead to the activation of gene expression.
Studies of this type need to be interpreted with caution. For example, the increased ratio of medial to adventitial angiotensinogen mRNA levels could be due to a decreased expression in the adventitia, but this possibility was excluded since the absolute grain counts in the adventitia were not different between the noninjured and injured vessels (Tables 1 and 2 ). Moreover, due to the technical difficulties inherent in performing in situ hybridization, a twofold increase, although statistically significant, may be misleading. Furthermore, the presence of angiotensinogen mRNA does not prove that angiotensinogen is in fact synthesized in these cells. While we are unaware of evidence suggesting translational control of angiotensinogen mRNA, the possibility exists that this mRNA is not translated in the vessel wall. Due to the lack of readily available antibodies directed toward angiotensinogen, immunohistochemistry could not be performed. However, these experiments would have been difficult to interpret due to the light of these caveats, our data demonstrate the presence of angiotensinogen mRNA within the media and developing neointima. Moreover, the results suggest that the medial expression is enhanced after injury and that the neointimal expression is highest during the first few weeks, at a time of rapid SMC growth. The fact that the medial expression of angiotensinogen mRNA in the control uninjured rats did not change supports this view.
The pathophysiological significance of the increased angiotensinogen expression in the tunical media in response to injury is worthy of speculation. Increased local angiotensin production may contribute to the development of the myointimal hyperplasia. In vitro, Ang II has been shown to induce the expression of c-f0os,8 c-jun,'9 and c-myc,20 three protooncogenes that are intimately associated with cell growth and division. Moreover, we have shown that Ang II induces the expression of PDGF A-chain mRNA and protein. 20 In addition to their growth-promoting abilities, both Ang II and PDGF have been shown to increase migration of SMCs.21"22 Thus, the transient increase in medial angiotensinogen expression may play an important role in the initiation of medial SMC replication and migration. These initial events are thought to be key to the subsequent development of the intimal lesion. Currently, it is unclear to what extent the effects of ACE inhibitors and angiotensin antagonist on intimal hyperplasia are due to their inhibition on these initial events.
Of potential interest is the finding that the proliferating neointima also expresses angiotensinogen mRNA. As with the medial angiotensinogen mRNA levels, the levels in the intima are highest 1 or 2 weeks after injury. It is unclear if the cells that express angiotensinogen mRNA in the neointima are the same SMCs that migrated into the intima and proliferated or if the expression is in other cell types that have infiltrated the lesion. These results suggest that the cells in the neointima can produce angiotensin that may amplify the proliferative process. In vitro under most conditions, Ang II stimulates hypertrophy rather than hyperplasia.23 However, the Ang II induction of protooncogenes and PDGF-A chain should elicit a proliferative response of the smooth muscle. This may be balanced by the Ang II induction of TGF-13 expression, which appears to play a modulating role to Ang II's mitogenic effect. 24 We have demonstrated that the addition of anti-TGF-P antibody to cultured vascular SMCs that were stimulated with Ang II resulted in the unmasking of a mitogenic response. Thus, the stimulation of autocrine growth factor gene expressions determines the growth response of vascular SMCs.
How does Ang II facilitate SMC proliferation in the balloon-injured blood vessel? Since the endothelium appears to play an important role in modulating the SMC growth state, we hypothesize that certain endothelial-derived factors must antagonize Ang II's growthpromoting effect on the SMC under normal conditions. This modulating effect of the endothelium is suggested by the observations that the vascular SMC turnover rate in a blood vessel is very slow in the presence of the endothelium25 and that PDGF expression cannot be detected in the normal vessel wall.26 Infusion of Ang II to animals with an intact endothelium resulted in a very modest induction of PDGF expression27 compared with large pool of circulating angiotensinogen. Evaluated in a 10-fold increase in tissue cufture experiments.20 How-ever, removal of endothelium resulted in marked increases in PDGF expression and proliferation of vascular SMCs. 27 We postulate that after balloon injury, the absence of endothelium unmasks Ang II's direct growth effect on vascular smooth muscle. In the absence of endothelial growth inhibitory factors, the proliferative pathway will be favored resulting in growth of vascular SMCs. Moreover, PDGF released by activated platelets and fibroblast growth factor (FGF) released by damaged endothelial cells are also present in high concentration after vascular injury. Furthermore, myointimal cells themselves can express autocrine PDGF and FGF. In this setting, angiotensin has been shown to amplify the mitogenic response of vascular SMCs to PDGF and FGF,28 thereby enhancing the development of the proliferative lesion.
In summary, our data demonstrate the presence of angiotensinogen mRNA in the media and neointima of the injured vessel. Moreover, the results suggest that the expression is highest in the first 2 weeks, a time of rapid cell growth. In light of the growth-promoting effects of Ang II both in vivo and in vitro, this expression of angiotensinogen mRNA, especially in the developing neointima, may play a role in the formation of the neointimal lesion.
